Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

breast cancer screening mammography

Combining neural network with breast density measurements boosts interval cancer detection rates

With up to 30% of breast cancers developing in between screenings, there is a great need to improve risk assessments, experts discussed recently in Radiology.

MR-guided thermoseeds can destroy cancerous brain tissue

"Improving the precision of treatment delivery is arguably the greatest unmet need we have in contemporary medicine," experts explained in Advanced Science.

Thumbnail

Machine learning model accurately predicts DCIS upstaging without invasive surgery

Understanding a patient's risk of developing invasive cancer without having to undergo surgery could help patients and providers choose more appropriate treatment plans.

RSNA21: Two-thirds of states did not prioritize vulnerable cancer patients during initial COVID vaccine rollout

Regulators must ensure that vulnerable populations receive their booster shots in a timely fashion.

Thumbnail

While promising, machine learning still misses 20% of cancers on breast MRIs, analysis shows

AI proved useful for detecting axillary lymph node metastases but isn’t yet ready for clinics, experts said recently.

Thumbnail

DBT plus synthesized mammography drops patients’ dosage without losing imaging quality

The combined breast screening technique also improves cancer detection rates, new research shows.

dollar money graph increase finance

CMS raising rate for outpatient lung cancer screening by more than 37% in final rule

The update is part of a slew of changes in the Medicare Hospital Outpatient Prospective Payment System final rule. 

Thumbnail

Many nationally recognized cancer centers are not complying with price transparency rules

The lack of cooperation may be hindering efforts to rein in cancer costs and improve affordability, oncology experts explained recently.